Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: PNNL, Aushon, and More

Premium

Richard Smith, director of proteomics at Pacific Northwest National Laboratory, has been named recipient of the 2013 Award for a Distinguished Contribution in Mass Spectrometry by the American Society for Mass Spectrometry.

Smith was selected for his work on the electrodynamic ion funnel, a technology used in a wide range of mass spectrometers. He will receive the award, which comes with a $10,000 cash prize, at this year's ASMS Annual Conference June 9-13 in Minneapolis, Minn.


Nanosphere said this week that it has appointed Ken Bahk to be chief strategy officer, a new position, and that company Chief Technology Officer Tim Patno will be leaving the company, as will Chad Mirkin, a member of the board of directors.

Bahk was part of Nanosphere's initial team, and served with the company until 2008. In the new post, he will be responsible for driving strategic plans and revenues in molecular diagnostics.

He currently is a director of investments at Lurie Investments, where he focuses on the diagnostics and life sciences areas. He also formerly was chair of strategic opportunities for the Association for Molecular Pathology.


Life Technologies said in a filing with the US Securities and Exchange Commission that Arnold Levine has retired from its board of directors, and that the company's stockholders have elected George Adam; Raymond Dittamore; Donald Grimm; Craig Mundie; Ora Pescovitz; and Per Peterson to serve on the board until the 2014 meeting.


Aushon Biosystems has appointed Susan Vogt to be company CEO. Vogt has 30 years of experience in the life sciences, pharmaceutical, biotech, and clinical diagnostics markets, Aushon said.

She has held executive posts at SeraCare Life Sciences and at Millipore, and she currently is a non-executive director of TAP BioSystems.


Quest Diagnostics has appointed Jim Davis, former VP at three GE healthcare businesses, to be senior VP of diagnostic solutions, where he will take over for Kathy Ordonez, who plans to leave the company.

In the position, Davis will oversee diagnostic products, insurer services, clinical trials, healthcare IT, and employer solutions.

Davis previously was CEO of InSightec, and he held VP and GM roles at GE’s MRI, diagnostic imaging, and healthcare IT businesses.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.